Biblioteca Hospital 12 de Octubre

Effect of CPAP on Blood Pressure in Patients With Obstructive Sleep Apnea and Resistant Hypertension The HIPARCO Randomized Clinical Trial. (Registro nro. 716)

000 -CABECERA
Campo de control de longitud fija na a22 4500
003 - IDENTIFICADOR DEL NÚMERO DE CONTROL
Campo de control PC716
005 - FECHA Y HORA DE LA ÚLTIMA TRANSACCIÓN
Campo de control 20191107130804.0
008 - CÓDIGOS DE INFORMACIÓN DE LONGITUD FIJA
Campo de control de longitud fija 130622s2013 xxx||||| |||| 00| 0 eng d
040 ## - FUENTE DE LA CATALOGACIÓN
Centro transcriptor H12O
041 ## - CÓDIGO DE LENGUA
Código de lengua del texto/banda sonora o título independiente eng
100 ## - PUNTO DE ACCESO PRINCIPAL - NOMBRE DE PERSONA
Nombre de persona Díaz de Atauri Rodríguez de los Ríos, María Josefa
9 (RLIN) 1172
Término indicativo de función Neumología
245 00 - MENCIÓN DE TÍTULO
Título Effect of CPAP on Blood Pressure in Patients With Obstructive Sleep Apnea and Resistant Hypertension The HIPARCO Randomized Clinical Trial.
Tipo de material [artículo]
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Nombre del editor distribuidor etc. Jama-Journal of the American Medical Association,
Fecha de publicación distribución etc. 2013
300 ## - DESCRIPCIÓN FÍSICA
Extensión 310(22):2407-15.
500 ## - NOTA GENERAL
Nota general Formato Vancouver:
Martínez-García MA, Capote F, Campos-Rodríguez F, Lloberes P, Díaz de Atauri MJ, Somoza M et al. Spanish Sleep
Network. Effect of CPAP on blood pressure in patients with obstructive sleep apnea and resistant hypertension: the HIPARCO randomized clinical trial. JAMA. 2013 Dec 11;310(22):2407-15.
501 ## - NOTA DE “CON”
Nota de "Con" PMID: 24327037
504 ## - NOTA DE BIBLIOGRAFÍA; ETC.
Nota de bibliografía etc. Contiene 40 referencias
520 ## - NOTA DE SUMARIO; ETC.
Sumario etc. IMPORTANCE More than 70% of patients with resistant hypertension have obstructive sleep apnea (OSA). However, there is little evidence about the effect of continuous positive airway pressure (CPAP) treatment on blood pressure in patients with resistant hypertension. OBJECTIVE To assess the effect of CPAP treatment on blood pressure values and nocturnal blood pressure patterns in patients with resistant hypertension and OSA. DESIGN, SETTING, AND PARTICIPANTS Open-label, randomized, multicenter clinical trial of parallel groups with blinded end point design conducted in 24 teaching hospitals in Spain involving 194 patients with resistant hypertension and an apnea-hypopnea index (AHI) of 15 or higher. Data were collected from June 2009 to October 2011. INTERVENTIONS CPAP or no therapy while maintaining usual blood pressure control medication. MAIN OUTCOMES AND MEASURES The primary end point was the change in 24-hour mean blood pressure after 12 weeks. Secondary end points included changes in other blood pressure values and changes in nocturnal blood pressure patterns. Both intention-to-treat (ITT) and per-protocol analyses were performed. RESULTS A total of 194 patients were randomly assigned to receive CPAP (n = 98) or no CPAP (control; n = 96). The mean AHI was 40.4 (SD, 18.9) and an average of 3.8 antihypertensive drugs were taken per patient. Baseline 24-hour mean blood pressure was 103.4 mm Hg; systolic blood pressure (SBP), 144.2 mm Hg; and diastolic blood pressure (DBP), 83 mm Hg. At baseline, 25.8% of patients displayed a dipper pattern (a decrease of at least 10% in the average nighttime blood pressure compared with the average daytime blood pressure). The percentage of patients using CPAP for 4 or more hours per day was 72.4%. When the changes in blood pressure over the study period were compared between groups by ITT, the CPAP group achieved a greater decrease in 24-hour mean blood pressure (3.1 mm Hg [95% CI, 0.6 to 5.6]; P = .02) and 24-hour DBP (3.2 mm Hg [95% CI, 1.0 to 5.4]; P = .005), but not in 24-hour SBP (3.1 mm Hg [95% CI, -0.6 to 6.7]; P = .10) compared with the control group. Moreover, the percentage of patients displaying a nocturnal blood pressure dipper pattern at the 12-week follow-up was greater in the CPAP group than in the control group (35.9% vs 21.6%; adjusted odds ratio [OR], 2.4 [95% CI, 1.2 to 5.1]; P = .02). There was a significant positive correlation between hours of CPAP use and the decrease in 24-hour mean blood pressure (r = 0.29, P = .006), SBP (r = 0.25; P = .02), and DBP (r = 0.30, P = .005). CONCLUSIONS AND RELEVANCE Among patients with OSA and resistant hypertension, CPAP treatment for 12 weeks compared with control resulted in a decrease in 24-hour mean and diastolic blood pressure and an improvement in the nocturnal blood pressure pattern. Further research is warranted to assess longer-term health outcomes.
710 ## - PUNTO DE ACCESO ADICIONAL - NOMBRE DE ENTIDAD
9 (RLIN) 88
Nombre de entidad o nombre de jurisdicción como elemento inicial Servicio de Neumología
856 ## - LOCALIZACIÓN Y ACCESO ELECTRÓNICOS
Identificador Uniforme del Recurso (URI) http://pc-h12o-es.m-hdoct.a17.csinet.es/pdf/pc/7/pc716.pdf
Acceso Solicitar documento
942 ## - ENTRADA PARA ELEMENTOS AGREGADOS (KOHA)
Suprimido en OPAC Público
Fuente de clasificación o esquema de ordenación en estanterías
Koha [por defecto] tipo de item Artículo
Existencias
Suprimido Estado de pérdida Fuente de clasificación o esquema de ordenación en estanterías Estropeado No para préstamo Localización permanente Localización actual Fecha de adquisición Signatura completa Fecha última consulta Fecha del precio de reemplazo Tipo de item de Koha
          Hospital Universitario 12 de Octubre Hospital Universitario 12 de Octubre 2019-11-07 PC716 2019-11-07 2019-11-07 Artículo

Con tecnología Koha